Benefit-Risk Management

ONLY 1 OFFERING IN 2017! Our best-in-class instructors teach you the Do’s and Don’ts for BRM over the lifecycle of the product, and the course includes the Rev 2 of the GVP Modules V and XVI.

Back to Agenda

SESSION 10: BENEFIT-RISK MANAGEMENT PLAN – CASE STUDIES

Session Chair(s)

Jan Petracek, MD, MSc

CEO

Ivigee, Czech Republic

Small molecules and generics
Biologics and biosimilars
Advanced therapies
Combination therapies

Speaker(s)

Small Molecule Group Work

Michael Forstner, PhD, MPH, MSc

SOBI, Switzerland

Head of Global Safety Science

Combination Product Group Work

Jan Petracek, MD, MSc

Ivigee, Czech Republic

CEO

Biologic Group Work

Jan Petracek, MD, MSc

Ivigee, Czech Republic

CEO

Advanced Therapies Group Work

Jan Petracek, MD, MSc

Ivigee, Czech Republic

CEO

Have an account?

Benefit-Risk Management

SESSION 10: BENEFIT-RISK MANAGEMENT PLAN – CASE STUDIES

Session Chair(s)

Jan Petracek, MD, MSc

Speaker(s)

Small Molecule Group Work

Combination Product Group Work

Biologic Group Work

Advanced Therapies Group Work

Be informed and stay engaged.